ReviewFrontiers in bioengineering and biotechnology2026
Innovative microneedle-integrated hydrogels: a promising strategy for diabetic foot ulcer management.
Review in Frontiers in bioengineering and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Targeting the FOXO4-p53 axis by retro-inverso peptide senolytic agents: a pharmacological strategy to mitigate brain aging and cognitive decline.Naunyn-Schmiedeberg's archives of pharmacology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetic foot ulcer (DFU) is a common and severe complication in diabetic patients, characterized by prolonged wound healing, susceptibility to infection, and a high risk of amputation. Its complex pathophysiology involves persistent hyperglycemia, chronic inflammation, neuropathy, vascular impairment, infection, and cellular dysfunction. Conventional treatments often fall short in addressing these multifaceted challenges, Therefore, formulating safe and effective treatment strategies holds significant clinical significance. In recent years, Microneedle Hydrogels have emerged as a novel drug delivery system due to their minimally invasive application, high drug loading capacity and controlled release characteristics, This review highlights the unique advantages of Microneedle Hydrogel systems, including their structural characteristics, drug delivery capabilities, and mechanisms in promoting ulcer healing. At the same time, the challenges currently faced in research and the future development directions were explored, aiming to provide references for further research and clinical application in this field.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.